The global artificial organs and bionics market size was USD 37.64 billion in 2023, calculated at USD 41.15 billion in 2024 and is expected to be worth around USD 100.31 billion by 2034. The market is slated to expand at 9.32% CAGR from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Artificial Organs and Bionics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Artificial Organs and Bionics Market Revenue and Volume, By Product, 2024-2033
8.1.1 Artificial Organs
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Kidney
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Heart
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Lungs
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Liver
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
8.1.6. Pancreas
8.1.6.1. Market Revenue and Volume Forecast (2021-2033)
8.1.7. Artificial Bionics
8.1.7.1. Market Revenue and Volume Forecast (2021-2033)
8.1.8. Cochlear Implant
8.1.8.1. Market Revenue and Volume Forecast (2021-2033)
8.1.9. Exoskeleton
8.1.9.1. Market Revenue and Volume Forecast (2021-2033)
8.1.10. Bionic Limbs
8.1.10.1. Market Revenue and Volume Forecast (2021-2033)
8.1.11. Vision Bionics
8.1.11.1. Market Revenue and Volume Forecast (2021-2033)
8.1.12. Vision Bionics
8.1.12.1. Market Revenue and Volume Forecast (2021-2033)
9.1. Artificial Organs and Bionics Market Revenue and Volume, By Technology, 2024-2033
9.1.1. Mechanical Bionics
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Electronic Bionics
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1. North America
10.1.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.1.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.1.3.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.1.4.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.2.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.2.3.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.2.4.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.2.5.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.2.6.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.3.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.3.3.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.3.4.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.3.5.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.3.6.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.4.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.4.3.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.4.4.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.4.5.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.4.6.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.5.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.5.3.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, By Product (2021-2033)
10.5.4.2. Market Revenue and Volume Forecast, By Technology (2021-2033)
11.1. Medtronic Plc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Boston Scientific Corporation
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Zimmer Biomet
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Edwards Lifesciences Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Jarvik Heart, Inc
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Cochlear Ltd
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. SynCardia Systems, LLC
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Berlin Heart
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Ekso Bionics
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. ABIOMED
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample